I agree, that question had asked whether it needed to finish the expansion (bile duct) or not - that part wasn’t responded to. so I feel has got our hopes up, whereas I think the understood consensus on HC was that we’d need 10 of the same indication to apply for this.
the answer does seem to imply very soon, not Q42024 or later.
will have to listen again but sounds like they are starting to prioritise bile cancer clients at current doses since they’ve achieved responses at current levels.
Ann: Imugene Investor Webinar - MAST Study Update, page-106
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |